Subtopic Deep Dive
Age-Related Macular Degeneration Epidemiology
Research Guide
What is Age-Related Macular Degeneration Epidemiology?
Age-Related Macular Degeneration Epidemiology studies the global prevalence, incidence, risk factors, and projections of AMD through systematic reviews and meta-analyses in aging populations.
Systematic reviews estimate AMD prevalence at 8.7% in Europe for late-stage disease (Li et al., 2019, 341 citations). Global Burden of Disease analyses project rising vision impairment from AMD over 30 years (Bourne et al., 2020, 1227 citations). Incidence meta-analyses in American whites report 2.7 per 1000 person-years for late AMD (Rudnicka et al., 2015, 173 citations).
Why It Matters
AMD epidemiology informs public health strategies for aging populations, as highlighted in the Lancet Global Health Commission projecting increased eye disease burden (Burton et al., 2021, 1353 citations). Prevalence data guide resource allocation in Europe, where AMD causes most visual impairment (Li et al., 2019). Incidence trends in whites enable forecasting healthcare needs amid demographic shifts (Rudnicka et al., 2015). These insights support preventive interventions and policy planning for rising global cases.
Key Research Challenges
Heterogeneous Prevalence Data
Systematic reviews reveal varying AMD prevalence across regions due to diagnostic criteria differences (Li et al., 2019). Meta-analyses struggle with study heterogeneity, impacting pooled estimates (Rudnicka et al., 2015). Standardized methods are needed for comparable global data.
Projecting Future Incidence
Global Burden models forecast AMD rise but face uncertainties in aging demographics (Bourne et al., 2020). Limited longitudinal data hinder accurate late-stage projections (Rudnicka et al., 2015). Integrating genetics adds complexity (DeAngelis et al., 2017).
Risk Factor Attribution
Epidemiology links AMD to age and demographics, but quantifying contributions remains challenging (Burton et al., 2021). Genetic factors complicate environmental risk modeling (DeAngelis et al., 2017). Subgroup analyses by ethnicity lack sufficient data.
Essential Papers
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020
Matthew J. Burton, Jacqueline Ramke, Ana Patrícia Marques et al. · 2021 · The Lancet Global Health · 1.4K citations
Executive Summary<br/>Eye health and vision have widespread and profound implications for many aspects of life, health, sustainable development, and the economy. Yet nowadays, many people, families...
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
Rupert Bourne, Jaimie D Steinmetz, Seth Flaxman et al. · 2020 · The Lancet Global Health · 1.2K citations
Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis
Jeany Q. Li, Thomas Welchowski, Matthias Schmid et al. · 2019 · British Journal of Ophthalmology · 341 citations
Background/Aims Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in Europe. A further increase in the number of affected persons is expected and current E...
Automatic detection of 39 fundus diseases and conditions in retinal photographs using deep neural networks
Ling‐Ping Cen, Jie Ji, Jianwei Lin et al. · 2021 · Nature Communications · 305 citations
Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
Federico Ricci, Francesco Bandello, Pierluigi Navarra et al. · 2020 · International Journal of Molecular Sciences · 192 citations
Age-related macular degeneration (AMD) constitutes a prevalent, chronic, and progressive retinal degenerative disease of the macula that affects elderly people and cause central vision impairment. ...
Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis
Alicja R. Rudnicka, Venediktos Kapetanakis, Zakariya Jarrar et al. · 2015 · American Journal of Ophthalmology · 173 citations
Estimating AMD incidence from prevalence allows better characterization at older ages and by AMD subtype where longitudinal data from incidence studies are limited.
Genetics of age-related macular degeneration (AMD)
Margaret M. DeAngelis, Leah A. Owen, Margaux A. Morrison et al. · 2017 · Human Molecular Genetics · 172 citations
Age-related macular degeneration (AMD) is a progressive blinding disease and represents the leading cause of visual impairment in the aging population. AMD affects central vision which impairs one'...
Reading Guide
Foundational Papers
Start with Hyman (1987, 140 citations) for elderly eye disease epidemiology basics, then Rudnicka et al. (2015) for AMD incidence meta-analysis to build prevalence understanding.
Recent Advances
Study Bourne et al. (2020, 1227 citations) for 30-year trends and Li et al. (2019, 341 citations) for European meta-analysis to grasp current projections.
Core Methods
Core techniques include systematic reviews, meta-analyses for pooling prevalence (Li et al., 2019), and Global Burden modeling for trends (Bourne et al., 2020).
How PapersFlow Helps You Research Age-Related Macular Degeneration Epidemiology
Discover & Search
Research Agent uses searchPapers and exaSearch to find meta-analyses like Li et al. (2019) on European AMD prevalence. citationGraph reveals connections from Bourne et al. (2020) to global burden studies. findSimilarPapers expands to Rudnicka et al. (2015) incidence data.
Analyze & Verify
Analysis Agent applies readPaperContent to extract prevalence rates from Li et al. (2019), then verifyResponse with CoVe checks consistency across Bourne et al. (2020). runPythonAnalysis performs meta-regression on incidence data from Rudnicka et al. (2015) using pandas. GRADE grading assesses evidence quality for high-burden projections.
Synthesize & Write
Synthesis Agent detects gaps in non-European projections via gap detection on Burton et al. (2021). Writing Agent uses latexEditText and latexSyncCitations to draft reports citing Li et al. (2019), with latexCompile for publication-ready PDFs. exportMermaid visualizes prevalence trends over time.
Use Cases
"Extract prevalence rates from AMD epidemiology papers and plot by region using Python."
Research Agent → searchPapers('AMD prevalence meta-analysis') → Analysis Agent → readPaperContent(Li et al. 2019) + runPythonAnalysis(pandas plot of rates from Li, Bourne) → matplotlib graph of European vs global trends.
"Write a LaTeX section on AMD incidence projections with citations."
Synthesis Agent → gap detection on Rudnicka et al. (2015) → Writing Agent → latexEditText('incidence section') → latexSyncCitations(Bourne 2020, Li 2019) → latexCompile → formatted PDF with projections table.
"Find code for AMD risk modeling from related papers."
Research Agent → searchPapers('AMD epidemiology code') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for prevalence simulation from similar retinopathy models.
Automated Workflows
Deep Research workflow conducts systematic reviews by chaining searchPapers on 50+ AMD papers like Burton et al. (2021), producing structured reports with GRADE scores. DeepScan analyzes heterogeneity in Li et al. (2019) via 7-step verification with runPythonAnalysis. Theorizer generates hypotheses on genetic-epidemiology links from DeAngelis et al. (2017) and Rudnicka et al. (2015).
Frequently Asked Questions
What is Age-Related Macular Degeneration Epidemiology?
It studies AMD prevalence, incidence, and projections via meta-analyses, estimating 8.7% late AMD in Europe (Li et al., 2019).
What methods are used in AMD epidemiology?
Systematic reviews and meta-analyses pool data, as in Bourne et al. (2020) for global trends and Rudnicka et al. (2015) for incidence.
What are key papers on AMD epidemiology?
Li et al. (2019, 341 citations) on European prevalence; Bourne et al. (2020, 1227 citations) on vision impairment trends; Rudnicka et al. (2015, 173 citations) on US incidence.
What open problems exist in AMD epidemiology?
Challenges include heterogeneous data, future projections amid aging, and risk factor integration (Burton et al., 2021; DeAngelis et al., 2017).
Research Retinal and Optic Conditions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Age-Related Macular Degeneration Epidemiology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Retinal and Optic Conditions Research Guide